Positive TB Blood Test: What Happens Next?

Contact the clinician or service that ordered the test and arrange medical evaluation for tuberculosis, or TB, disease. A TB blood test, often called an interferon-gamma release assay or IGRA, measures an immune response to TB proteins. A positive result usually indicates TB infection, but does not by itself show whether you have TB disease or need a particular treatment.

CDC guidance recommends evaluating people with a positive result for TB disease. Do not label the result ‘latent TB’ solely because you feel well. This adult guide helps you prepare the report and history for that assessment; children and people with particular medical circumstances need their own clinical pathway. If an assessment is already arranged, keep it and clarify any missing instructions.

WHO's 2025 diagnosis guideline distinguishes tests for TB infection from investigations for TB disease. IGRAs are indirect immune-response tests, not a way to determine the amount of bacteria or diagnose active disease from a blood value. A positive result also cannot calculate your individual chance of developing disease in the future.

The clinician must assess whether TB disease is present before describing the condition as latent or inactive TB infection. Not everyone with TB disease has noticeable symptoms. The result alone therefore cannot tell you whether you are infectious. Ask the treating service about any precautions for your situation rather than inferring them from how you feel or from someone else's test result.

Keep the laboratory, collection date, report date, test name and full interpretation together. Copy ‘positive’ exactly as reported. ‘Borderline,’ ‘indeterminate’ and ‘invalid’ are different result categories whose meaning depends on the test; do not rewrite one as positive. If the only information you received was a portal alert, ask for the complete report.

Include numerical values, units, control results and laboratory comments when provided, without trying to convert them into a severity or infectiousness score. CDC notes that specific guidance for interpreting quantitative IGRA results is not available; clinicians consider them with the qualitative result and risk context. Ask whether the report is final and whether any clarification is needed. Do not arrange your own repeat-test schedule to resolve the uncertainty.

Look for previous blood-test or skin-test reports, TB-clinic letters, relevant chest-imaging reports and records of treatment for TB infection or TB disease. Record where and approximately when care occurred if documents are missing. Ask the receiving team which records it needs and how to obtain them; do not delay contacting it while building a complete archive.

CDC explains that TB blood tests may remain positive after treatment has finished. A later positive result is not, by itself, a treatment-failure or reinfection test. Bring the actual treatment summary if available: the diagnosis recorded, medicines listed, dates, any interruption and whether completion was documented. Mark ‘completion uncertain’ if you do not know. Do not assume that another course is needed or that previous treatment settles the current assessment.

Tell the clinician about previous BCG vaccination, but do not use it to dismiss a positive IGRA. BCG can affect a TB skin test; CDC distinguishes this from TB blood tests, which are unaffected by BCG vaccination. Confirm which kind of test you actually had rather than applying a skin-test explanation to a blood result.

Singapore's National Tuberculosis Programme explains that a positive blood test does not establish when infection occurred or prove that a particular recent contact was its source. Give relevant exposure or screening history privately to the clinical team when requested. This worksheet does not ask you to identify other people, investigate contacts yourself or publish anyone's medical information.

Explain why testing was done, any symptoms and their duration, previous TB care and relevant health conditions or medicines. Tell the team about immune-system conditions, treatments that suppress immunity and pregnancy where relevant. Assessment may involve examination, chest imaging and appropriate samples or other investigations selected by the clinician. This is not a universal list of tests to obtain yourself.

WHO's 2024 preventive-treatment guidance places screening and ruling out TB disease before preventive treatment within a programme-led assessment. The investigations and pathway depend on the population, clinical circumstances and national guidance. Ask what has been assessed, what is pending and whether the current conclusion is final. Treatment selection, if indicated, also needs professional review of your history and medicines; do not start, borrow, stop or restart TB medicines from an online plan.

Use this original record privately with the responsible service. It is a communication aid, not a diagnostic score, contact-tracing form or clearance certificate. Send reports only through the clinic's approved channel; do not post identifiable reports or other people's details on SameCase.

• Ordering service and reason for testing: ___; result-review contact ___; assessment arranged or request sent on ___.
• Current report: laboratory ___; test name ___; sample/report dates ___; exact interpretation ___; numerical values, units, controls and comments attached if reported ___.
• Previous TB testing: test type/date/result and source document ___; unavailable record and likely holder ___.
• Previous TB assessment or treatment: recorded diagnosis ___; service/dates ___; treatment summary and completion documentation available / requested / uncertain ___.
• Current clinical information to discuss privately: symptoms or none noticed ___; onset/duration ___; relevant conditions, actual medicines and other context the team requests ___.
• Assessment status: examination or investigations already completed ___; clinician's explanation ___; pending item and responsible service ___.
• Next instructions: appointment and contact ___; service's precautions, if any ___; result-explanation date ___; contact if instructions or results are missing ___.

Tell the service promptly about a persistent cough, fever, night sweats, unexplained weight loss or feeling unwell, including when these started. These symptoms have several possible causes and need clinical assessment. Contact the clinic before attending to explain the positive result and any symptoms and ask how it wants you to attend. Do not wait for a repeat blood test or enough records to complete the worksheet.

Coughing up even small flecks or streaks of blood needs urgent medical advice. Seek local emergency help for more than a few spots or streaks, or coughing blood with breathing difficulty, a very fast heartbeat, or chest or upper-back pain. NHS guidance separates these emergency features from smaller amounts that still require urgent assessment. New seizures, sudden confusion, or a severe headache with a stiff neck also need emergency assessment; do not assume their cause is TB. Do not drive yourself for emergency care.

Ask: ‘What does this positive result mean after my assessment? Has TB disease been excluded, is it suspected, or are we still waiting for information? Who will explain the remaining results and what should I do meanwhile?’ Keep the clinician's exact explanation separate from the laboratory result and record any change in the plan.

If testing came through an employer, school or another programme, clarify which clinical service is responsible for medical follow-up. This article does not decide work, travel or immigration requirements. Keep a copy of the final assessment and any treatment documentation for future clinical discussions; do not treat a repeat positive or negative result as a substitute for that record.